皇將

+0.20 (+0.75%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

26.7018成交張數17.68本益比1.22股價淨值比3.75%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

元

負債總額 / 資產總額

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	23	12	46.7%	1.98	21.28	7.3%	4.0%	-0.0	-0.0
2026Q1	22	12	44.3%	1.71	21.58	9.5%	5.1%	0.7	0.7
2025Q4	21	13	39.3%	2.14	23.39	10.9%	6.0%	0.8	0.1
2025Q3	21	12	44.6%	1.77	21.36	9.7%	5.1%	0.2	0.2
2025Q2	21	11	45.8%	1.70	20.54	6.5%	3.5%	-0.5	-0.6
2025Q1	22	12	47.7%	1.64	21.09	5.6%	2.9%	0.0	0.0
2024Q4	23	12	45.2%	1.79	21.29	3.5%	1.8%	1.5	1.5
2024Q3	22	11	44.1%	1.95	20.79	1.0%	0.5%	0.1	0.1
2024Q2	22	12	42.4%	2.07	21.15	4.7%	2.3%	-0.1	-0.1
2024Q1	23	12	44.6%	1.94	20.95	6.8%	3.2%	0.6	0.3
2023Q4	22	12	43.0%	2.08	20.98	1.3%	0.7%	-0.3	-0.3
2023Q3	23	11	47.5%	1.90	20.65	-2.3%	-1.1%	0.6	0.5
2023Q2	24	11	50.1%	1.79	21.42	-1.2%	-0.5%	-0.1	-0.2
2023Q1	22	10	57.0%	2.06	18.44	-1.0%	-0.4%	-0.7	-0.7
2022Q4	21	11	49.9%	2.55	20.55	5.8%	2.7%	0.6	0.6
2022Q3	22	9	58.2%	1.67	20.43	10.9%	4.5%	2.5	2.5
2022Q2	22	9	59.0%	1.61	19.22	11.7%	4.7%	-1.5	-1.5
2022Q1	21	8	59.4%	1.60	18.33	8.8%	3.6%	-0.1	-0.1
2021Q4	21	9	56.9%	1.70	18.80	8.7%	3.9%	0.3	0.3
2021Q3	21	9	58.8%	2.21	18.10	8.1%	3.5%	-0.2	-0.2
2021Q2	21	8	60.5%	2.13	17.33	6.3%	2.6%	0.6	0.5
2021Q1	20	8	58.2%	2.37	17.39	10.4%	4.7%	0.2	0.2
2020Q4	19	9	53.6%	2.83	18.43	7.6%	3.5%	0.7	0.7
2020Q3	19	9	54.7%	2.80	18.07	8.6%	4.3%	1.7	1.6
2020Q2	19	8	55.7%	2.69	17.70	9.1%	4.4%	-1.0	-1.0
2020Q1	19	9	52.0%	3.08	19.24	6.0%	3.1%	-0.5	-0.5
2019Q4	20	9	52.9%	3.25	19.78	10.2%	5.3%	0.0	-0.0
2019Q3	16	9	42.8%	3.11	19.17	9.8%	5.6%	0.2	0.2
2019Q2	16	9	46.5%	2.17	18.70	–	–	-0.0	-0.0
2019Q1	16	9	42.7%	2.65	19.83	–	–	0.6	0.6
2018Q4	16	9	42.1%	2.74	19.49	–	–	0.2	0.1
2018Q3	16	9	42.7%	2.73	20.03	–	–	–	–